Latest News

Monday, June 29, 2015 | Retina, Bayer

Eylea (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion

Regeneron Pharmaceuticals announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, received approval for Eylea (aflibercept) Injection by the Ministry of Health, Labour and Welfare (M…

Read the full story

Monday, June 29, 2015 | Partnerships, NightstaRx

NightstaRx and The University of Alberta announce the start of the first Canadian Gene Therapy Study to Treat Choroideremia

NightstaRx announced that the University of Alberta has begun enrolling and dosing subjects in a phase II clinical trial of the company’s gene therapy for the treatment of choroideremia (CHM), a…

Read the full story

Friday, June 26, 2015 | Earnings & Financials, Glaukos Corporation

Glaukos Stock Skyrockets 73% in IPO

Glaukos became available for public trade on the NYSE under the symbol "GKOS" on Thursday. Prior to trading, Glaukos announced the pricing of its initial public offering of 6,000,000 shares …

Read the full story

Friday, June 26, 2015 | Product Releases, Haag Streit

Haag-Streit Releases The Toric Suite

The Lenstar is the first optical coherence biometer to provide the surgeon with all the measurements necessary to take full advantage of the latest toric IOL prediction methods like Barrett, Holladay …

Read the full story

Friday, June 26, 2015 | Medical Studies

Annual Global IOL Procedures are Expected Reach Nearly 30 Million by 2020

Market Scope expects the global IOL procedures to climb from roughly 24.4 million procedures in 2015 to nearly 30 million procedures in 2020 at a compounded annual rate of 3.6%, according to a company…

Read the full story

Thursday, June 25, 2015 | Product Releases, Alcon Laboratories

Alcon Launches New Hydrogen Peroxide-Based Contact Lens Cleaning and Disinfecting Solution in the US

Alcon announced the US launch of Clear Care Plus Cleaning & Disinfecting Solution containing HydraGlyde Moisture Matrix technology, for cleaning and disinfecting contact lenses, according to…

Read the full story

Thursday, June 25, 2015 |

Second Sight Appoints Will McGuire as President and CEO

Second Sight Medical Products announced the appointment of Will McGuire, a 20-year veteran of the life sciences industry, as president and chief executive officer, effective August 18, 2015. Mr. McGui…

Read the full story

Thursday, June 25, 2015 | Medical Studies

Plugging the Tear Ducts Helps Some With Dry Eyes

Tiny plugs inserted into the tear duct may safely curb the annoying and damaging effects of dry eyes, according to a new analysis of previous research. "Plugs are generally well tolerated," …

Read the full story

Wednesday, June 24, 2015 | Management/Leadership

Dennis Pardo joins ZeaVision as Vice President of Medical and Professional Affairs

Dennis Pardo, OD, MPH, FAAO, has joined ZeaVision as vice president of medical and professional affairs, according to a company news release. ZeaVision is the parent company of EyePromise, a doctor-re…

Read the full story

Wednesday, June 24, 2015 | Clinical Trials, Ocata Therapeutics

Ocata Therapeutics Announces Positive Results for Patients Who Received Retinal Pigmented Epithelium Cell Therapy for Macular Degeneration

Data presented in a late-breaking abstract at the International Society for Stem Cell Research 13th annual meeting being held in Stockholm, Sweden, June 24-27 provided a follow-up of four prospective …

Read the full story

Wednesday, June 24, 2015 | Medical Studies

New mVT Research Shows Significant Value for AMD and DR Patients

Vital Art and Science released four new studies in the continuing scientific investigations of its newly launched mVT Service, a medical device that tracks the progression of maculopathies, according …

Read the full story

Wednesday, June 24, 2015 | Medical Studies

Patient-Reported Vision Improves After Ocriplasmin for Vitreomacular Adhesion

Patients report meaningful improvements in vision after ocriplasmin treatment for vitreomacular adhesion (VMA), according to a pair of multicenter trials. "For those patients with symptomatic VMA…

Read the full story

Tuesday, June 23, 2015 | Cataract Surgery, Imprimis Pharmaceuticals

Imprimis Pharmaceuticals Acquires Proprietary Compounded Conscious Sedation Formulations

Imprimis Pharmaceuticals announced that it has acquired the rights to novel proprietary sedation and analgesia/anesthesia formulations that, once prescribed and dispensed for an individual patient, ar…

Read the full story

Tuesday, June 23, 2015 | Clinical Trials, Second Sight Medical Products

Second Sight Announces Positive Long-Term Results of the Argus II Retinal Prosthesis System

Second Sight Medical Products announced positive 3-year results post-implant of its Argus II Retinal Prosthesis System from a multicenter clinical trial, according to a company news release. The pa…

Read the full story

Tuesday, June 23, 2015 | Grants/Awards

Research to Prevent Blindness Awards RPB Stein Innovation Award to University of Louisville Ophthalmology Researcher Douglas Dean

Douglas Dean, PhD, the Robert W. Rounsavall Jr. and Gretchen C. Rounsavall Endowed Chair in Ocular Molecular Biology in the Department of Ophthalmology and Visual Sciences at the University of Louisvi…

Read the full story
Load More
 Stock Price  Change 
 Actavis $298.98  0.00% 
 Aerie Pharmaceuticals, Inc. $17.18  0.00% 
 Akorn, Inc. $42.54  0.00% 
 Alimera Sciences, Inc. $4.50  0.00% 
 Avalanche Biotechnologies $15.28  0.00% 
 Bayer $142.35  0.14% 
 Can-Fite Biopharma $2.22  0.00% 
 Carl Zeiss Meditec $22.91  2.53% 
 Cooper Companies, Inc. $176.75  0.00% 
 Eleven Biotherapeutics $2.82  0.00% 
 Escalon Medical Corp. $1.42  0.00% 
 Essilor International $122.74  0.00% 
 Imprimis Pharmaceuticals, Inc. $8.17  0.00% 
 InSite Vision, Inc. $0.19  0.00% 
 IRIDEX Corporation $8.29  0.00% 
 Johnson & Johnson $97.68  0.00% 
 Luxottica Group, S.p.A. $67.18  0.00% 
 Merck & Company, Inc. $57.29  0.00% 
 NicOx $1.87  1.19% 
 NovaBay Pharmaceuticals, Inc. $0.64  0.00% 
 Novartis AG Common Stock $98.53  0.00% 
 Ocular Therapeutix $21.44  0.00% 
 Ophthotech Corporation $50.14  0.00% 
 QLT $4.07  0.00% 
 Quantel $2.95  3.15% 
 Regeneron $504.97  0.00% 
 Roche $35.31  0.00% 
 Second Sight Medical Products $13.72  0.00% 
 STAAR Surgical Company $9.76  0.00% 
 TearLab Corporation $2.05  0.00% 
 Thrombogenics $5.50  0.00% 
 Topcon Corporation $21.43  0.00% 
 Valeant Pharmaceuticals $220.31  0.00% 
 Xoma $3.66  0.00%